These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 32306353)
21. Evaluation of 5'-nuclease and hybridization probe assays for the detection of shiga toxin-producing Escherichia coli in human stools. Schuurman T; Roovers A; van der Zwaluw WK; van Zwet AA; Sabbe LJ; Kooistra-Smid AM; van Duynhoven YT J Microbiol Methods; 2007 Sep; 70(3):406-15. PubMed ID: 17614150 [TBL] [Abstract][Full Text] [Related]
22. The effects of the carboxyl-terminus amino acids of the Shiga toxin B-subunit on retrograde transport. Liu D; Fan Y; Li J; Gao X; Hao M; Xue H; Tai G Mol Med Rep; 2012 Jul; 6(1):220-6. PubMed ID: 22552548 [TBL] [Abstract][Full Text] [Related]
23. AB5 Preassembly Is Not Required for Shiga Toxin Activity. Pellino CA; Karve SS; Pradhan S; Weiss AA J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129 [TBL] [Abstract][Full Text] [Related]
24. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692 [TBL] [Abstract][Full Text] [Related]
25. Characterization of rabbit polyclonal sera against recombinant Shiga toxin and its subunits for detection of Stx-producing E. coli. Oloomi M; Bouzari S Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):41-6. PubMed ID: 21358014 [TBL] [Abstract][Full Text] [Related]
26. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303 [TBL] [Abstract][Full Text] [Related]
27. Environmental Cues Modulate Microglial Cell Behavior Upon Shiga Toxin 2 From Enterohemorrhagic Berdasco C; Duhalde Vega M; Rosato-Siri MV; Goldstein J Front Cell Infect Microbiol; 2019; 9():442. PubMed ID: 31970091 [TBL] [Abstract][Full Text] [Related]
28. Receptor affinity, stability and binding mode of Shiga toxins are determinants of toxicity. Shimizu T; Sato T; Kawakami S; Ohta T; Noda M; Hamabata T Microb Pathog; 2007; 43(2-3):88-95. PubMed ID: 17532600 [TBL] [Abstract][Full Text] [Related]
29. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain. Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616 [TBL] [Abstract][Full Text] [Related]
30. Shiga toxin A subunit mutant of Escherichia coli O157:H7 releases outer membrane vesicles containing the B-pentameric complex. Kim SH; Lee SR; Kim KS; Ko A; Kim E; Kim YH; Chang KT FEMS Immunol Med Microbiol; 2010 Apr; 58(3):412-20. PubMed ID: 20199568 [TBL] [Abstract][Full Text] [Related]
31. Baicalein Inhibits Stx1 and 2 of EHE: Effects of Baicalein on the Cytotoxicity, Production, and Secretion of Shiga Toxins of Enterohaemorrhagic Escherichia coli. Vinh PT; Shinohara Y; Yamada A; Duc HM; Nakayama M; Ozawa T; Sato J; Masuda Y; Honjoh KI; Miyamoto T Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31470657 [TBL] [Abstract][Full Text] [Related]
32. Biochemical Characterization of In vitro Reconstituted Biologically Active Recombinant Shiga Toxin. Chauhan V; Chauhan R; Sonkar P; Dhaked RK Protein Pept Lett; 2019; 26(3):227-234. PubMed ID: 30592251 [TBL] [Abstract][Full Text] [Related]
33. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals. Mainil J Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357 [TBL] [Abstract][Full Text] [Related]
34. Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor. Johansson K; Willysson A; Kristoffersson AC; Tontanahal A; Gillet D; Ståhl AL; Karpman D Front Cell Infect Microbiol; 2020; 10():212. PubMed ID: 32523894 [TBL] [Abstract][Full Text] [Related]
35. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity. Perera LP; Samuel JE; Holmes RK; O'Brien AD J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714 [TBL] [Abstract][Full Text] [Related]
36. Correlation between Shiga toxin B-subunit stability and antigen crosspresentation: a mutational analysis. Pina DG; Stechmann B; Shnyrov VL; Cabanié L; Haicheur N; Tartour E; Johannes L FEBS Lett; 2008 Jan; 582(2):185-9. PubMed ID: 18070601 [TBL] [Abstract][Full Text] [Related]
37. Tumor Targeting with Bacterial Shiga Toxin B Subunit in Genetic Porcine Models for Colorectal Cancer and Osteosarcoma. Ehrenfeld M; Schrade A; Flisikowska T; Perl M; Hirsch ND; Sichler A; Geyer L; Flisikowski K; Wilhelm D; Schober SJ; Johannes L; Schnieke A; Janssen KP Mol Cancer Ther; 2022 Apr; 21(4):686-699. PubMed ID: 35086950 [TBL] [Abstract][Full Text] [Related]
38. Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli. Cilmi SA; Karalius BJ; Choy W; Smith RN; Butterton JR J Infect Dis; 2006 Oct; 194(8):1135-40. PubMed ID: 16991089 [TBL] [Abstract][Full Text] [Related]
39. Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy. Danielewicz N; Rosato F; Tomisch J; Gräber J; Wiltschi B; Striedner G; Römer W; Mairhofer J ACS Omega; 2023 May; 8(17):15406-15421. PubMed ID: 37151527 [TBL] [Abstract][Full Text] [Related]
40. Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells. Nakagawa I; Nakata M; Kawabata S; Hamada S Mol Microbiol; 1999 Sep; 33(6):1190-9. PubMed ID: 10510233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]